Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel M Freed

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Structure (London, England : 1993)|January 24, 2018
Regulation of Kinase Activity in the Caenorhabditis elegans EGF Receptor, LET-23Lijun Liu, Tarjani M Thaker, Daniel M Freed, et al.
Cell|October 10, 2017
EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling KineticsDaniel M Freed, Nicholas J Bessman, Anatoly Kiyatkin, et al.
Scientific Reports|May 5, 2023
Activity of pemetrexed in pre-clinical chordoma models and humansSantosh Kesari, Feng Wang, Tiffany Juarez, et al.
Nature Communications|April 6, 2023
Mapping the landscape of genetic dependencies in chordomaTanaz Sharifnia, Mathias J Wawer, Amy Goodale, et al.
JCO Precision Oncology|July 2, 2025
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in ChordomaDaniel S Lefler, Andrew Elliott, Wei Jiang, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2026
A pooled analysis of phase 2 clinical trials in advanced chordomaGregory M Cote, Corrine F Elliott, Astrid Lipplaa, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Structure (London, England : 1993)|January 24, 2018
Regulation of Kinase Activity in the Caenorhabditis elegans EGF Receptor, LET-23Lijun Liu, Tarjani M Thaker, Daniel M Freed, et al.
Cell|October 10, 2017
EGFR Ligands Differentially Stabilize Receptor Dimers to Specify Signaling KineticsDaniel M Freed, Nicholas J Bessman, Anatoly Kiyatkin, et al.
Scientific Reports|May 5, 2023
Activity of pemetrexed in pre-clinical chordoma models and humansSantosh Kesari, Feng Wang, Tiffany Juarez, et al.
Nature Communications|April 6, 2023
Mapping the landscape of genetic dependencies in chordomaTanaz Sharifnia, Mathias J Wawer, Amy Goodale, et al.
JCO Precision Oncology|July 2, 2025
Pansarcoma Analysis of Cyclin-Dependent Kinase and Cyclin Outlier Gene Expression Highlights CDK7 as a Potential Therapeutic Target in ChordomaDaniel S Lefler, Andrew Elliott, Wei Jiang, et al.
European Journal of Cancer (Oxford, England : 1990)|June 16, 2026
A pooled analysis of phase 2 clinical trials in advanced chordomaGregory M Cote, Corrine F Elliott, Astrid Lipplaa, et al.
Pageof 2